abstract |
The invention provides human Alzheimer's disease-associated proteins (ADP) and polynucleotides which identify and encode ADP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ADP. |